title: Willingness to receive an HIV vaccine among incarcerated persons.
abstract: BACKGROUND
  Once an HIV vaccine becomes available, high-risk adults will be a target population for vaccination, and HIV vaccination programs for inmates may be a public health priority. Nothing is known about U.S. inmates' willingness to accept an anticipated HIV vaccine while incarcerated. The goal of this study was to examine inmates' attitudes toward a potential HIV vaccine.
  
  
  METHODS
  In 2002, we interviewed 153 male and female inmates at the Rhode Island Department of Corrections (RIDOC) using a voluntary, anonymous survey.
  
  
  RESULTS
  Ninety-three percent of inmates indicated they would be willing to receive a hypothetical HIV vaccine while incarcerated. Although 88% of inmates self-reported at least one HIV risk factor, only 20% perceived themselves to be at risk for HIV.
  
  
  CONCLUSIONS
  Once an HIV vaccine becomes available, HIV vaccination programs in the correctional setting need to become a public health priority. These would be well received by inmates in Rhode Island.
authors.affiliation: Brown University School of Medicine, Providence, RI 02906, USA. mlally@lifespan.org
authors.forename: Michelle
authors.initials: M
authors.lastname: Lally
authors.forename: Melissa
authors.initials: M
authors.lastname: Gaitanis
authors.forename: Snigdha
authors.initials: S
authors.lastname: Vallabhaneni
authors.forename: Steven
authors.initials: S
authors.lastname: Reinert
authors.forename: Kenneth
authors.initials: K
authors.lastname: Mayer
authors.forename: Gregory
authors.initials: G
authors.lastname: Zimet
authors.forename: Josiah
authors.initials: J
authors.lastname: Rich
mesh_terms: D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D010342:Patient Acceptance of Health Care; D011329:Prisoners / Q000523:psychology*; D011634:Public Health / Q000639:trends; D012237:Rhode Island; D014765:Viral Vaccines
chemical_list: D014765:Viral Vaccines